Magenta Therapeutics Inc logo

Magenta Therapeutics Inc

STU:3MT (USA)  
€ 0.68 (+1.19%) Sep 11
At Loss
Market Cap:
€ 39.60M ($ 41.23M)
Enterprise V:
€ -32.80M ($ -34.15M)
Volume:
-
Avg Vol (2M):
-
Trade In:

Business Description

Description
Magenta Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing novel medicines to extend the curative power of stem cell transplant, gene therapy, genome editing, and cell therapy. The pipeline of the company includes MGTA-117, MGTA-145, MGTA-45 and others.
Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History
6-1 Month Momentum % 6.47
12-1 Month Momentum % -61.49

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History

GF Value Rank

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2025-05-15 Est.)

STU:3MT's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Magenta Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €)
EPS (TTM) (€) -1.088
Beta 0
Volatility % 108.85
14-Day RSI 0
14-Day ATR (€) 0.015429
20-Day SMA (€) 0
12-1 Month Momentum % -61.49
52-Week Range (€) 0.302 - 1.96
Shares Outstanding (Mil) 60.66

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Magenta Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Magenta Therapeutics Inc Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Magenta Therapeutics Inc Frequently Asked Questions

What is Magenta Therapeutics Inc(STU:3MT)'s stock price today?
The current price of STU:3MT is €0.68. The 52 week high of STU:3MT is €1.96 and 52 week low is €0.30.
When is next earnings date of Magenta Therapeutics Inc(STU:3MT)?
The next earnings date of Magenta Therapeutics Inc(STU:3MT) is 2025-05-15 Est..
Does Magenta Therapeutics Inc(STU:3MT) pay dividends? If so, how much?
Magenta Therapeutics Inc(STU:3MT) does not pay dividend.

Press Release

Subject Date
No Press Release